Background
In the co ntext of this wo rk , a "bo l u s"is a solid ora l dosage fo rm for administration of one or more t h e ra peutic agents to a large animal.A bolus ca n co ntain a large amount of drug re l at i ve to the ty p i cal co nte nt of a dosage fo rm for humans.Th e d eve l o p m e nt of an in vitro dissolution test for a bolus pre s e nts seve ral challenges: s e l e ction or design of an appro p ri ate dissolution apparatus and i d e nt i f i cation or fo rm u l ation of a dissolution medium capable of providing sink conditions and s u f f i c i e nt buffer ca p a c i ty.
The object i ve of this re s e a rch paper is to ex p l o re the deve l o p m e nt of a po te ntially discri m i n ating in v i t ro dissolution test for ve te ri n a ry boluses using USP Ap p a ratus 2.The widespread ava i l a b i l i ty of this a p p a ratus makes it a co m pelling choice,p a rt i c ul a rly when co nt ra s ted with the ex pense of bo t h e q u i p m e nt and chemicals for larger vo l u m e te s t i n g.Th u s,the object i ve was to use 900 mL or less of an aqueous dissolution media at 37 ° C,w i t h a stirring rate less than or equal to 100 RPM.
Sulfa drugs we re chosen for ex a m i n ation of the issues assoc i ated with in vitro testing of bo l u s e s : S u l f a d i m e t h oxine where each bolus co ntains 5 g of s u l f a d i m e t h ox i n e ;S u l f a c h l o rpy ra d a z i n e,w h e re each bolus co ntains 2 g of sulfachlorpy ra d a z i n e ; and Sulfamethazine,w h e re each bolus co ntains 5 g of sulfamethazine.
Solubility
It is generally desirable to study dissolution under sink co n d i t i o n s.For the purpose of this a n a l ys i s,the assumption is made that sink co n d itions are met when the solubility of the dru g,u n d e r the conditions of the te s t,is 10 times the maximum co n ce nt ration that would occur if the dosage of d rug we re to co m p l e tely dissolve.When using USP Ap p a ratus 2,the ty p i cal volume is 900 mL.Th e initial step in design of the method is an assessm e nt of aqueous solubility.As a general ru l e,t h e default selection for the medium is deionize d wate r.In most situations the solubility of the drug in water alone will not be sufficient .Wh e n eve r po s s i b l e,it is pre fe rable to avoid the use of solubil i zers and co s o l ve nt s.
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For a drug with one or more we a kly acidic and/or basic functional gro u p ( s ) ,which is not subject to rapid specific acid or base cat a l ys i s,the pH of the medium may be adjusted to acco m m od ate the l a rge quant i ty being dissolve d.Howeve r,it is impo rt a nt to re cog n i ze that the dissolution of the dru g itself may lead to a significa nt pH change if the dissolution medium does not have sufficient buffe r ca p a c i ty.Th e re fo re it is cri t i cal to identify the pH at which sufficient solubility can be obtained,a n d then design a buffer sys tem such that it will maintain that pH.
St a n d a rd solubility re l ationships may be used to i d e ntify the appro p ri ate pH for the dissolution te s t . Howeve r,s u b s t a ntial dev i ations from ideal be h avior should be ex pe cted given the high dru g and buffer co n ce nt rations that will be pre s e nt . These dev i ations should be acco u nted fo r,and this first step in developing a suitable method depe n d s u pon the ava i l a b i l i ty of "re a l"s o l u b i l i ty dat a .
Ge n e ra l l y,d ev i ations from ideal be h avior can be a d e q u ately dealt with by using a "f u n ct i o n a l"d i s s oc i ation co n s t a nt rather than one that may have been dete rmined in dilute solution.A funct i o n a l d i s s oc i ation co n s t a nt is one that includes the ove rall effe ct of the act i v i ty coe f f i c i e nts of the c h e m i cal species part i c i p ating in an equilibri u m re l ationship without explicit dete rm i n ation of these act i v i ty coe f f i c i e nt s.
For ex a m p l e,consider the drug sulfadimethox i n e [SDMH] which has a single we a kly acidic funct i o n a l g ro u p :
w h e re SDMH and SDM-re fer to the acidic (undiss oc i ated) and ionized (dissoc i ated) fo rms of the d ru g,re s pe ct i ve l y.The designations (SDMH) and (SDM-) re fer to the molar co n ce nt rations of these s pe c i e s,and St = total drug solubility.The dissoc i at i ve equilibrium is chara cte ri zed in Eq 3,w h e re K a.SDMH = dissoc i ation co n s t a nt for the dru g,and a H + re fers to the act i v i ty of the hyd ronium ion in solution as assessed by po te nt i o m e t ric measure m e nt with a co m b i n ation pH elect rod e.The te rms γ S D M H and γ S D M -a re the act i v i ty coe f f i c i e nts for the acidic and ionized fo rms of the dru g,re s pe ct i ve l y.K a ' . S D M H = the functional dissoc i ation co n s t a nt for the dru g which gove rns the re l at i ve co n ce nt rations of s u l f a d i m e t h oxine chemical species in solution as a f u n ction of pH.In this analys i s,an assumption is made that K a ' S D M H is indeed co n s t a nt ;an equiva l e nt assumption is that the act i v i ty coe f f i c i e nt rat i o γ S D M H /γ S D M -is co n s t a nt .From a theore t i cal po i nt of v i e w,one would ex pe ct the act i v i ty coe f f i c i e nt of a c h a rged species to be more sensitive to changes in the ionic strength of the env i ro n m e nt than an u n c h a rged spe c i e s.Howeve r,t h e re is co nv i n c i n g ev i d e n ce to indicate that the assumption of a co n s t a nt act i v i ty coe f f i c i e nt ratio int rod u ces only a s l i g ht bias in this and subsequent analyses (see Bu f fer Sys tem sect i o n ,page 10).
With re g a rd to Eq.5 ,So = int rinsic solubility of the d ru g,which in this case is (SDMH) and which is co n s t a nt in the po rtion of the pH-solubility pro f i l e w h e re the solid phase is the weak acid.
Si n ce dev i ations from ideal be h avior are ex pe cte d,and are significa nt,it is nece s s a ry to "f i t" real data to Eq.5 .Usually an approach where So and p Ka'a re va ried sequent i a l l y,u ntil the theore t i ca l re l ationship visually co nve rges with the real dat a ,i s a d e q u ate.(In this ca s e,the final para m e te r s, ex p ressed to three significa nt figure s,co rre s po n d to a minimum sum of the squares of the residuals at the pH values where actual data was ava i l a b l e. )
Real data for SDMH we re obtained from the Me rck Index ( 1 ) .Fi g u re 1 is a pH-solubility profile fo r SDMH which includes that data and co m p a res it to a theore t i cal profile based on Eq.5 ,with the O n ce the int rinsic solubility and functional dissoc i ation co n s t a nt have been ident i f i e d,it is po s s i b l e to dete rmine the pH where St is 10 times the maximum co n ce nt ration that will be observed at 100% dissolution.For the SDMH bo l u s,5 g of dru g in 900 mL co rre s ponds to a co n ce nt ration of 5.56 g/L (0.0179 M).To achieve sink conditions wo u l d re q u i re a solubility of 55.6 g/L.Based on Eq 4,a pH of 8.74 would prod u ce a sys tem where the solub i l i ty is 55.5 g/L.Th u s,the buffer sys tem must be designed so that a pH of no lower than 8.74 will exist at the end of the dissolution proce s s. E xte n s i ve solubility data is not readily available in the lite rat u re for the other drugs selected here. Howeve r,t h ey are stru ct u rally similar weak acids and it was ant i c i p ated that the dissolution medium designed for SDMH would also wo rk for the other sulfa dru g s.Another aspe ct of dissolution method d eve l o p m e nt,which is not emphasized here,is to m a ke sure that the drug is sufficiently stable in the dissolution medium to allow for an accurate assessm e nt of the dissolution be h av i o r.
Buffer System
If pH adjustment is the approach taken to i n c rease solubility,then it is essential to make sure t h at the sys te m's pH is at (or above in this case) that n e ce s s a ry to acco m m od ate the dru g.Si n ce the d rug itself is an acid,and a large quant i ty will be d i s s o l ve d,its dissolution will decrease pH and change the sys tem in a manner that decre a s e s ove rall solubility.While changes in pH are i n ev i t a b l e,it is desirable to keep the change to a m i n i m u m .For this wo rk , an arbitra ry maximum change of 0.5 pH units was established as a goal.
A high buffer ca p a c i ty is essent i a l ,and as a g e n e ral rule one must choose a buffer sys tem that has a pK a 've ry close to the target pH.Even so,it will be nece s s a ry to utilize re l at i vely high buffe r co n ce nt rations to achieve the design goal,a n d o n ce again substantial dev i ations from ideal be h avior are to be ex pe cte d.If po s s i b l e,one should also avoid organic buffers that absorb light in the UV range so that simple analysis may be acco mplished using spe ct ro s co py.
A bo rate buffer sys tem was selected for the dissolution medium.The USP Al kaline Bo rate buffe r s ys tem was employed as a set of real solution dat a t h at allow an estimate of the functional pK a 'of the b u f fer re p re s e nting the fo l l owing equilibri u m :
w h e re H 3 Bor and H 2 Bor-re fer to bo ric acid and the monobasic bo rate ion. A pro ton balance equation (3) for a bo rate buffe r s ys tem made by combining bo ric acid and sod i u m hyd roxide would be :
Eq. ( 7 ) w h e re (OH-) = hyd roxide ion co n ce nt rat i o n ,( H 2 Bo r -) = bo rate ion co n ce nt rat i o n ,and b = co n ce nt ration of s t rong base (i.e. ,Na O H ) .In this equat i o n ,(OH-) and ( H 2 Bor-) co n ce nt rations co rre s pond to the co n ce nt rations of hyd ronium ion co nt ri b u ted by water and bo ric acid,re s pe ct i ve l y,while b co rre s ponds to the co n ce nt ration of hyd ronium ion neutra l i zed by the addition of the strong base. Co n s i d e ring the re s pe ct i ve equilibrium re l at i o ns h i p s,Eq.7 may also be wri t ten as:
Eq. ( 8 ) with K w = dissoc i ation co n s t a nt for wate r,Ct = b u f fer co n ce nt rat i o n ,and K a ' . B O R = functional dissoc i ation co n s t a nt for bo ric acid.O n ce again,the re a l d ata may be used to estimate K a ' . B O R by sequent i a l l y va rying para m e ters in Eq.7 until data from the t h e o re t i cal re l ationship co nve rges with the re a l d at a .These va ri ations can be done easily on a s p re a d s h e e t,and the fo l l owing table re p re s e nts the results of such a process where Ct = 0.05 M. In this ca s e,the pH values used are those spe c ified in the USP.O n ce pH is stipulate d,(OH-) and ( H 2 Bo r -) can be dete rmined from equilibrium re l ationships and b can be ca l c u l ated from Eq. Now that functional pK a 'values have been dete rmined for both the drug and the selected buffe r,i t is possible to proceed to the actual design of the b u f fer sys te m .
Si n ce the pK a 'for SDMH is 5.54 and the dissolution process will nece s s a rily be co n d u cted at or a bove pH 8.74,SDMH will be at least 2 pH units a bove its pKa and will be h ave like a strong acid, co nt ributing its available pro tons to the solution. Another way to say this is that the co n ce nt ration of u n d i s s oc i ated SDMH pre s e nt at pH 8.8 or above will be essentially ze ro.
Th u s,the dissolution of SDMH in the bo rate b u f fer sys tem could be re p re s e nted by the fo l l owing pro ton balance equat i o n :
Eq. ( 9 ) w h e re,be cause of the low pK a ,(SDM-) = co n ce nt ration of SDMH dissolve d. By stipulating the initial pH and co n ce nt ration of a buffer sys te m ,it is then possible to estimate the pH that would result as SDMH dissolve s,by solving Eq.9 for (SDM-) at va rious pH's.Fi g u re 2 re p re s e nts a t h e o re t i cal plot of pH vs amount dissolved in a 0.15 M pH 9.0 Bo rate buffer sys te m .The graph also includes data from an actual dissolution te s t d e s c ri bed be l ow.It can be seen that the pH resulting after the dissolution of a 5 g bolus will be a bout 8.75.This co rre s ponds well to the targ e t established in the pH -solubility analys i s.
Dissolution of Sulfadimethoxine Boluses
Dissolution testing of sulfadimethoxine bo l u s e s was initially co n d u cted using USP Ap p a ratus 2 at 37° C and 75 RPM,with the 0.15 M pH 9.0 Bo rate Bu f fer as the medium.An auto m atic sampler wa s e m p l oye d,and prog rammed to co l l e ct 3.5 mL at each of the fo l l owing time po i nt s :5 ,1 0 ,2 0 ,3 0 ,4 5 and 60 minute s.The plan was to analyze by U V s pe ct ro s co py at 268 nm,using 0.01 cm path length cells in an at tempt to avoid sample dilution. Howeve r,a n a l ysis of standards indicated that this would not be possible for sulfadimethox i n e,and a 1:10 dilution of samples was re q u i re d.Sa m p l e s f rom vessel 3 we re arbitra rily selected for pH m e a s u re m e nt,and the results of these measurem e nts are included in Fi g u re 2.
The sulfadimethoxine boluses te s ted disinteg rated quickl y,and the resulting quant i ty of solid in d i s persion in the dissolution flask was quite larg e. Initial testing was pe rfo rmed with 0.45 micron inline filte r s ;h oweve r,s eve ral lines be came clog g e d d u ring the run and manual sampling was pe ri od ically nece s s a ry.In all ca s e s,samples we re cloudy and we re filte red after co l l e ction using a 0.45 m i c ron syringe filte r.S u b s e q u e nt at tempts without the in-line filters re s u l ted in clogging of the dip t u be s,and resolving this issue will re q u i re additional wo rk .
Dissolution results from this initial test are p re s e nted in Fi g u re 3,and coo rd i n ate gra m s Di s s o l ved and pH measure m e nts are included in Fi g u re 2.
These results suggest that the dissolution medium wo rks we l l ,and that the boluses te s te d d i s p l ay ve ry little va ri ation in drug release at the time po i nts te s te d.Howeve r,it is ev i d e nt that the 60 m i n u te time frame was not sufficient to obtain 100% release with an RPM of 75.
A more co m p re h e n s i ve analysis was co n d u cte d at RPM's of 50,7 5 ,and 100 using the same apparatus and co n d i t i o n s.These results are pre s e nted in Fi g u re 4,w h e re each profile is based on ave rages of 6 bo l u s e s ;the error bars included in the figures are based on ± 2 standard dev i at i o n s.The depe n d e n ce of dissolution exte nt on RPM's suggests that the m e t h od has the ability to discri m i n ate and may s e rve as an acceptable in vitro quality co nt ro l m e t h od.
Dissolution of Sulfachlorpyradazine and Sulfamethazine Boluses
S u l f a c h l o rpy radazine and sulfamethazine bo l u s e s we re also te s ted in the 0.15 M pH 9.0 bo rate buffe r m e d i u m ,and the results are pre s e nted in Fi g u res 5 and 6,re s pe ct i ve l y.The problems prev i o u s l y e n co u nte red with plugging of the filters did not occur in either of these dissolution studies.O n ce a g a i n ,each of the profiles pre s e nted re p re s e nt the mean of six bo l u s e s,and the error bars included are based on ± 2 standard dev i at i o n s.The 2 g boluses of s u l f a c h l o rpy radazine pre s e nted co m p l e te and re l at i vely rapid dissolution,with little effe ct of RPM on the pro f i l e.On the other hand,the 5 g sulfamethazine boluses pre s e nted slower dissolution with g re ater sensitivity to a change in stirring rate.
Conclusions
Po te ntially discri m i n ating in vitro dissolution testing of ve te ri n a ry boluses co ntaining sulfa dru g s with dosages up to 5 g can be accomplished using USP Ap p a ratus 2 with co nve ntional volumes and s t i rring rates in an aqueous medium spe c i a l l y designed to provide and maintain sink co n d i t i o n s. The design of an appro p ri ate buffer sys tem to be used as the dissolution medium for we a kly acidic or we a kly basic drugs can be accomplished by using s t a n d a rd theore t i cal re l ationships fitted to re a l s o l u b i l i ty and buffer dat a .
The 0.15 M pH 9.0 bo rate buffer sys te m e m p l oyed in this analysis admittedly is more co n ce nt rated than norm a l ,and the pH of 9.0 is outside of the pre fe rred range for testing of human d rug prod u ct s.While the phys i o l og i cal re l eva n ce of testing under these conditions for drugs in animals remains to be dete rm i n e d,the sulfadimethox i n e, s u l f a c h l o rpy ra d a z i n e,and sulfamethazine bo l u s e s te s ted all disinte g rated rapidly under the te s t conditions and each would have met a dissolution s pe c i f i cation of Q = 85% in 60 minutes at 75 RPM, for ex a m p l e. c h e m i ca l s,re a g e nts and prod u cts to be te s te d,and re l e a s e time was provided by Dr.Fa h my.Facilities and equipment we re generously provided by Un i ve r s i ty Ph a rm a ce u t i cals of Ma ry l a n d,I n c.The authors wish to thank Anna Ch a n ,Amy L aw and Mi ke Gi p p rich of UPM for their te c h n i cal suppo rt .
